Vanguard Investments Australia »

Day One Biopharmaceuticals I shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-03-31 $398k 19k 21.44

More positions owned by Vanguard Investments Australia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Investments Australia

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I